BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8225665)

  • 1. Spontaneous hemarthrosis following thrombolytic therapy for acute myocardial infarction.
    Birnbaum Y; Stahl B; Rechavia E
    Int J Cardiol; 1993 Jul; 40(3):289-90. PubMed ID: 8225665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous hemarthrosis following fibrinolytic therapy for acute myocardial infarction: a case report and literature review.
    Ramadan MM; Khan IS; Mahdi O
    Am J Case Rep; 2014 Nov; 15():514-7. PubMed ID: 25417208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous haemarthrosis following thrombolytic therapy for myocardial infarction.
    Oldroyd KG; Hornung RS; Jones AM; Andrews NP; Dawes PT; Carson PH
    Postgrad Med J; 1990 May; 66(775):387-8. PubMed ID: 2371191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous suprachoroidal hemorrhage secondary to thrombolysis for the treatment of myocardial infarction.
    Barsam A; Heatley CJ; Herbert L
    Clin Exp Ophthalmol; 2006 Mar; 34(2):177-9. PubMed ID: 16626438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review.
    Da Silva VF; Bormanis J
    Neurosurgery; 1992 Jun; 30(6):943-5. PubMed ID: 1614602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical aspects of using thrombolytic therapy in myocardial infarct at the prehospital stage].
    Staroverov II; Dundua DP; Plotnikov AN; Pomerantsev EV; Bliumental' AA; Puchkov AT; Ovasapian IuA; Serov VP; Ruda MIa
    Kardiologiia; 1993; 33(3):28-32. PubMed ID: 8377336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Van de Werf F
    J Am Coll Cardiol; 1993 Sep; 22(3):707-13. PubMed ID: 8354802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired hepatic function tests after thrombolysis for acute myocardial infarction.
    Freimark D; Leor R; Hod H; Elian D; Kaplinsky E; Rabinowitz B
    Am J Cardiol; 1991 Mar; 67(6):535-7. PubMed ID: 1900140
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemorrhagic aspects of thrombolytic therapy.
    Samama M
    Eur Heart J; 1990 Aug; 11 Suppl F():15-8. PubMed ID: 2121488
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?
    Collen D
    Ann Intern Med; 1990 Apr; 112(7):529-38. PubMed ID: 2107781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L; Lüderitz B
    Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemarthrosis of the knees following streptokinase therapy for acute myocardial infarction.
    Pimenta E; Anti SM
    Arq Bras Cardiol; 2003 Jun; 80(6):641-2, 639-2. PubMed ID: 12875278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.
    Boland A; Dundar Y; Bagust A; Haycox A; Hill R; Mujica Mota R; Walley T; Dickson R
    Health Technol Assess; 2003; 7(15):1-136. PubMed ID: 12773258
    [No Abstract]   [Full Text] [Related]  

  • 18. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemarthrosis following thrombolytic therapy for acute myocardial infarction.
    Finlayson J; Dunsmuir RA
    Injury; 1997 Mar; 28(2):146-7. PubMed ID: 9205584
    [No Abstract]   [Full Text] [Related]  

  • 20. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
    Lancet; 1990 Jul; 336(8707):71-5. PubMed ID: 1975322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.